New Non-Prescription, Breakthrough Cold Sore Medicine to Hit U.S. Shelves This Summer
Wednesday, July 8th, 2015
Cherry Hill, NJ (PRWEB) May 26, 2015
The brand new, over-the-counter product was developed in Switzerland and will be available in American retail stores for the first time ever this summer. The topical cold sore treatment forms a protective layer over the cold sore, stopping the spread of the virus. Zzip immediately relieves pain and halts itching. http://www.zzipUSA.com
ZZIP USA is proud to announce that ZZIP® Cold Sore medication will be available to the American consumer for the first time this summer. Zzip’s unique, proprietary and patented blend of natural and synthetic ingredients will extend to the U.S. what Europeans began discovering back in 2014. Zzip was developed and engineered in Switzerland by ZZIP AG amongst the natural beauty of the Swiss Alps. That particular region has a long and noted history for products designed with a keen attention to detail and superior ingredients. The Zzip proprietary and patented formula combines active ingredients Dimethicone, Menthol and Allantoin; along with inactive Alpine Rose extract, among other ingredients.
One cold sore sufferer says: “I have hit the lottery in finding Zzip.” Others say Zzip is unlike anything else they have tried: “Zzip quickly relieved the pain, halted itching and the result was indisputable.” Testimonials include people who have suffered 50 or more years of treating recurring cold sores. They say the product had truly unique attributes in immediate and sustained pain relief. You can hear Tom’s story here.
“In 25 years of creating and marketing a wide variety of supplements, cosmetics and other treatments that address ailments of the human condition,” says OTC Pharma CEO, Mario Oldani, “I have never been associated with a product that I believed has so much organic competitive advantages over the other offerings it competes against.” http://www.zzipUSA.com
Introducing the product in the two countries he calls home, Mario’s assessment proved true as the product quickly shot to the #2 bestselling item in the cold sore treatment/ lip care segment in both Switzerland and the Netherlands. After seeing the success of Zzip in Switzerland and the Netherlands, Boot’s, the U.K.’s largest Drug Store Chain, began carrying Zzip in February. Boot’s is owned by Illinois-based Walgreen’s.
“I remember where I was when I heard the news,” stated Martin Uniacke, VP of Sales of ZZIP USA, the American company that is the Exclusive importer of Zzip. “We were in Las Vegas at a pharmacy sales event focused on the Cough and Cold Category where we were making 80 presentations to many of the biggest mass, chain drug and grocery retailers and their distributors, when were told. A cut-in entry, that is to say an accelerated move to put a product on the shelves in one of the largest retail operations in their home market in Europe was a great show of acceptance and eagerness to want to carry the product.” http://www.zzipUSA.com
Uniacke looks ahead to future events. “We attended the ECRM show for the Cough and Cold Category in February in Hendersonville, NV near Las Vegas. We were well received by Walgreen’s, CVS, H.E.B., KMart, Smith Drug and SuperValu, as well as several major distributors and a host of regional independent pharmacies from across the country, many of whom we are following up with now,” says Uniacke.
“My decision to invest my time, energy and money into new endeavors are based on whether or not the initiative meets my ‘doing good and doing well’ litmus test. In the case of becoming the exclusive US importer of Zzip, the product surpassed my criteria,” says Garnick, CEO and Founder of GG Advisors, LLC dba ZZIP USA. “Millions of Americans suffer needlessly from cold sore breakouts due to the insidious HSV1 Virus. Most people don’t realize that an innocent kiss from Grandmom might have transmitted this incurable virus during ones childhood. Zzip’s unique blend of ingredients engineered by a skilled team of doctors and scientists in Switzerland, is an OTC Medicine that we know will help the millions of people who’ve given up on the current available remedies. The products available today simply have proven ineffective for a vast amount of cold sore suffers. We know if cold sore sufferers give Zzip a try that they, like so many Europeans already have experienced who have been using this non-prescription breakthrough medicine since late 2014, will finally get the relief from the painful, embarrassing and untimely cold sores that so many have been struggling with for too long.”
Zzip will be available to American consumers through Amazon in August. In addition, mainstream and local pharmacies across the country will soon carry Zzip, including Hi-School Pharmacy in the Pacific Northwest.
Inquires may contact: Robyn Stevens prmedia(at)live(dot)com 856-885-0913
http://www.zzipUSA.com
